Endometrial carcinoma from the standpoint of pathology: Current developments and perspectives

被引：0
|
作者：
Neppl C. [1 ]
Solass W. [2 ]
Christe L. [2 ]
Rau T.T. [1 ]
机构：
[1] Institut für Pathologie, Universitätsklinikum und Heinrich-Heine-Universität Düsseldorf, Moorenstr. 5, Düsseldorf
[2] Institut für Pathologie Bern, Universität Bern, Bern
来源：
Die Gynäkologie | 2023年 / 56卷 / 10期
基金：
英国科研创新办公室;
关键词：
Biomarker; Checkpoint inhibition; Immunohistochemistry; Micrometastases; Risk assessment;
D O I：
10.1007/s00129-023-05143-4
中图分类号：
学科分类号：
摘要：
The well-established four molecular subtypes (POLEmut, MMRd, NSMP, and P53abn) of endometrial carcinoma are today considered together with conventional morphological parameters in unified risk classifications. The clinical–therapeutic relevance lies especially in de-escalating concepts to avoid adjuvant therapies without benefit for POLEmut carcinomas. In more advanced stages, however, testing for checkpoint inhibition and anti-Her2 therapy might be considered. The aim of this review is to provide background information and suggestions for the practical implementation in clinical routine. © 2023, The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
引用
收藏
页码：718 / 725
页数：7
相关论文
共 48 条
  • [31] The utility of evaluating mismatch repair proteins in endometrial carcinoma: an experience from a tertiary referral centre in North India
    Jain, Ekta
    Prasad, Sarita
    Dhar, Aparna
    Kini, Lata
    Sharma, Shivani
    Dewan, Aditi
    PATHOLOGICA, 2021, 113 (02) : 115 - 120
  • [32] Testing for Lynch Syndrome in Endometrial Carcinoma: From Universal to Age-Selective MLH1 Methylation Analysis
    Pasanen, Annukka
    Loukovaara, Mikko
    Kaikkonen, Elina
    Olkinuora, Alisa
    Pylvaenaeinen, Kirsi
    Alhopuro, Pia
    Peltomaeki, Paeivi
    Mecklin, Jukka-Pekka
    Buetzow, Ralf
    CANCERS, 2022, 14 (05)
  • [33] Translating data into policy informing decisions: current and future perspectives from the European Food Safety Authority (EFSA)
    Anastassiadou, Maria
    Devos, Yann
    Dujardin, Bruno
    Eskes, Chantra
    Kouloura, Eirini
    Lopez-Galvez, Gloria
    Rizzi, Valentina
    Gilsenan, Mary Bridget
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2025,
  • [34] mTRAQ-based quantification of potential endometrial carcinoma biomarkers from archived formalin-fixed paraffin-embedded tissues
    DeSouza, Leroi V.
    Krakovska, Olga
    Darfler, Marlene M.
    Krizman, David B.
    Romaschin, Alexander D.
    Colgan, Terence J.
    Siu, K. W. Michael
    PROTEOMICS, 2010, 10 (17) : 3108 - 3116
  • [35] Undifferentiated Endometrial Carcinoma, an Immunohistochemical Study Including PD-L1 Testing of a Series of Cases From a Single Cancer Center
    Al-Hussaini, Maysa
    Lataifeh, Isam
    Jaradat, Imad
    Abdeen, Ghadeer
    Otay, Lian
    Badran, Osama
    Abu Sheikha, Areej
    Dayyat, Abdulmajeed
    El Khaldi, Mousa
    Al-Loh, Shaymaa Ashi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2018, 37 (06) : 564 - 574
  • [36] Therapeutic indications for antibody-drug conjugates estimated from HER2 and p53 expressions in endometrial carcinoma
    Nakajima, Junya
    Yano, Mitsutake
    Zaitsu, Sumika
    Kamada, Kouichi
    Yabuno, Akira
    Hasegawa, Kosei
    Kobayashi, Eiji
    Yasuda, Masanori
    HUMAN PATHOLOGY, 2024, 152
  • [37] Periocular Sebaceous Carcinoma: A Case Audit from the National Specialist Ophthalmic Pathology Service in Liverpool from 2009 to 2022 to Assess the Diagnostic Utility of PRAME Expression
    Salleh, Amizatul Aini
    Krishna, Yamini
    Coupland, Sarah E.
    OCULAR ONCOLOGY AND PATHOLOGY, 2024, 10 (01) : 1 - 8
  • [38] Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers IV: Current and Future Utilization of Molecular-Genetic Tests for Testicular Germ Cell Tumors
    Looijenga, Leendert H. J.
    Van der Kwast, Theodorus H.
    Grignon, David
    Egevad, Lars
    Kristiansen, Glen
    Kao, Chia-Sui
    Idrees, Muhammad T.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2020, 44 (07) : E66 - E79
  • [39] Mesonephric-like Differentiation of Endometrial Endometrioid Carcinoma: Clinicopathological and Molecular Characteristics Distinct from Those of Uterine Mesonephric-like Adenocarcinoma
    Park, Sujin
    Bae, Go Eun
    Kim, Jiyoung
    Kim, Hyun-Soo
    DIAGNOSTICS, 2021, 11 (08)
  • [40] Best practices for achieving consensus in HER2-low expression in breast cancer: current perspectives from practising pathologists
    Tozbikian, Gary
    Bui, Marilyn M.
    Hicks, David G.
    Jaffer, Shabnam
    Khoury, Thaer
    Wen, Hannah Y.
    Krishnamurthy, Savitri
    Wei, Shi
    HISTOPATHOLOGY, 2024, 85 (03) : 489 - 502
12345